- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Podcast: This Week in Managed Care—Verma on Health Data and Other Health News
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This week, the top managed care stories included Cigna's deal to buy Express Scripts; Seema Verma, Alex Azar, and Scott Gottlieb, MD, made the rounds at health conferences; an analysis finds FDA's accelerated approval pathway has been a success with hematology and oncology drugs.
Listen above or through one of these podcast services:
iTunes: http://apple.co/2eYWTss
TuneIn: http://bit.ly/2gv7iwj
Stitcher: http://bit.ly/2gCqtFg
Read more about the stories in this podcast:
Healthcare Mergers Continue With Deal for Cigna to Acquire Express Scripts
What We're Reading: Verma on Health Data; More Medicaid Work Requirements; NJ Individual Mandate
Azar Tells Insurance Industry Patients Must Be in Charge of Their Own Data
FDA's Gottlieb Blames Rebates, Reimbursement Issues for Holding Back Biosimilar Market
Expedited Approval Is Successful for Cancer Therapies, FDA Says
The Shift From Episodic to Continuous Care: Wearable Technology and Telemedicine in Cardiology
American College of Cardiology’s 67th Annual Scientific Session & Expo
Using AI, Socioeconomic Factors to Predict Outcomes After Allo-SCT for AML
August 16th 2025Artificial intelligence (AI) and socioeconomic factors enhance risk stratification for patients with acute myeloid leukemia (AML) post transplant, aiming to reduce hospital readmissions and disease progression.
Read More
AML Relapse Mirrors Pulmonary Hypertension Worsening in Rare Case
August 14th 2025A rare case report describes a young woman whose relapse of AML following MPN coincided with severe worsening of pulmonary hypertension, highlighting the need for vigilant cardiopulmonary monitoring in hematologic malignancies.
Read More
